Laboratory Applications for Oxymetholone Research
Pharma OXY 50 Pharmacom is a synthetic anabolic-androgenic steroid derived from dihydrotestosterone, formulated specifically for controlled laboratory research environments. This oxymetholone preparation enables researchers at Stroid UK Shop to investigate androgenic receptor binding mechanisms and anabolic pathway modulation in cellular models. The compound demonstrates high oral bioavailability in preclinical studies, making it valuable for examining steroid metabolism and tissue-specific androgenic effects in laboratory settings.
Research Applications and Mechanisms
Scientists frequently examine this oxymetholone formulation when studying protein synthesis enhancement and nitrogen retention mechanisms in muscle tissue cultures. The compound’s methylated structure at the 17α position confers resistance to hepatic metabolism, allowing researchers to analyse extended androgenic activity in experimental models. Investigations often focus on oxymetholone research compounds for their potent anabolic properties relative to testosterone, with studies indicating significant increases in red blood cell production and muscle protein accretion in animal models. Comparative studies alongside selective androgen receptor modulators help researchers understand tissue-selective androgenic mechanisms.
Technical Specifications
| Parameter | Value |
|---|---|
| Chemical Name | 17β-Hydroxy-2-(hydroxymethylene)-17α-methyl-3-androstanone |
| CAS Number | 434-07-1 |
| Molecular Formula | C₂₁H₃₂O₃ |
| Molecular Weight | 332.48 g/mol |
| Purity | Verify with supplier documentation |
| Storage | Room temperature, dry environment, protected from light |
Research teams investigating metabolic pathways often cross-reference oxymetholone studies with peptide research compounds to examine synergistic effects on cellular growth mechanisms. The compound’s structure enables detailed analysis of 5α-reductase enzyme interactions and downstream metabolite formation in hepatic cell cultures.
Research Compliance Information
Pharma OXY 50 Pharmacom is manufactured exclusively for in-vitro research applications within accredited laboratory facilities. This product is not intended for human consumption, therapeutic use, or any application outside controlled scientific investigation. Researchers must maintain appropriate safety protocols when handling androgenic compounds and ensure compliance with institutional research guidelines. All studies should be conducted under proper laboratory supervision with adequate documentation of experimental procedures and outcomes.
